View abstracts of studies supported by our research funding.

 
Select Filters
Apply Filters
Reset Filters

Cerebrovascular endothelial cilia in Alzheimer's Disease and hypertension

Wissam AbouAlaiwi, Ph.D.
Toledo, OH - United States
2022

Endothelial SOCS3 role in post-shock brain damage and cognitive impairment

Alejandro Adam, Ph.D.
Albany, NY - United States
2022

Outcomes and quality of life for people with dementia facing surgery

Rachel Adler, Sc.D.
Boston, MA - United States
2022

Co-Therapy of Nilotinib and Lithium for Treating Alzheimer’s disease

Aida Adlimoghaddam, Ph.D.
Winnipeg, Canada
2022

Association Between Biomarkers of Chronic Stress and Cognition in Latinos

Paula Aduen, Ph.D.
Boston, MA - United States
2022

Microglia Regulation of Alzheimer’s Disease Pathology and Progression

Bahareh Ajami, Ph.D.
Portland, OR - United States
2022

Role of child gut microbiota on adult Alzheimer's disease susceptibility

Ziad Al Nabhani, Ph.D.
Bern, Switzerland
2022

Early microglia–neuron interactions in Alzheimer's Disease

Giulia Albertini, Ph.D.
Gent, Belgium
2022

A New Prospect in Triggering Early Hyperexcitability in Alzheimer’s Disease

David Alcantara-Gonzalez, Ph.D.
Menands, NY - United States
2022

CGRP Pathways in Clinicopathogically -established Parkinson Disease

Athanasia Alexoudi, Ph.D.
Athens, Greece
2022

Engineered Decoy Viral Inhibitors (DEVi) to Prevent Tau Spread by LRP1

Gaya Amarasinghe, Ph.D.
St. Louis, MO - United States
2022

Health Outcomes of Transitional Space Design for Older Adults with Dementia

Diana Anderson, M.D., M. Arch
Boston, MA - United States
2022

Ancestry-specific effects of APOE on AD endophenotypes and risk factors

Shea J. Andrews, Ph.D.
New York, NY - United States
2022

Selective mTOR Inhibition to Treat Alzheimer's Disease

Zoltan Arany, M.D., Ph.D.
Philadelphia, PA - United States
2022

Microglia Structure and Function in Tau Pathology and During Treatment

Alejandro Avila, Ph.D.
New York, NY - United States
2022

Cellular events that shape microglial identity in Alzheimer's disease

Pinar Ayata, Ph.D.
New York, NY - United States
2022

Impact of White Adipose Tissue on Tau Pathology in Transgenic Mice

David Baglietto-Vargas, Ph.D.
Málaga, Spain
2022

Electrophysiological Measures of pProteinopathy in Asymptomatic Older Adults

Sylvain Baillet, Ph.D.
Montreal, Canada
2022

The role of epilepsy in Tau propagation in Alzheimer's Disease

Aaron Barbour, Ph.D.
Philadelphia, PA - United States
2022

Metabolic Trajectories of Alzheimer’s Disease Progression

Richa Batra, Ph.D.
Ithica, NY - United States
2022

Multimodal Imaging of Small Vessel Disease in Genetic AD

Alexandre Bejanin, Ph.D.
Barcelona, Spain
2022

Glial signatures of tau propagation in Alzheimer's disease

Bruna Bellaver, Ph.D.
Pittsburgh, PA - United States
2022

Assessing Technology Use in Activities of Daily Living

Jared Benge, Ph.D.
Austin, TX - United States
2022

Social connection in long-term care home residents

Jennifer Bethell, Ph.D.
Toronto, Canada
2022

Neuroregeneration in Alzheimer’s Disease

Sanjoy Bhattacharya, Ph.D.
Coral Gables, FL - United States
2022

Strategies Disrupting the Feed-Forward Mechanism of Aß Production.

Elena Anahi Bignante, Ph.D.
Cordoba, Argentina
2022

Tau and ApoE coalescence, the bridge to impaired brain lipid homeostasis

Melissa Birol, Ph.D.
Berlin, Germany
2022

Role of Rho GTPases during amyloid-ß induced neuronal degeneration

Mariano Bisbal, Ph.D>
Cordoba, Argentina
2022

Developing risk and resiliency models of neuropsychiatric symptoms in AD

Laura Blair, Ph.D.
Tampa, FL - United States
2022

Disclosing Dementia Risk Based on Plasma Phosphorylated Tau: A Pilot Study

Corey Bolton, Psy.D.
Nashville, TN - United States
2022

1 2 3 4 5 6 7 8 9 10... >|